Johnson & Johnson
JNJHealthcareDrug Manufacturers - General · US
Métriques clés
Prix actuel
243.04 USD
Market Cap
N/A
P/E Ratio
N/A
Secteur
Healthcare
À propos de Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various canc
Les données affichées sont issues de sources publiques (Financial Modeling Prep). Elles sont fournies à titre indicatif et ne constituent pas un conseil en investissement. Les métriques avancées (DCF, valeur intrinsèque, verdict IA) sont disponibles sur ValuEngine.
Voir l'analyse complète de Johnson & Johnson
Valorisation DCF interactive, analyse IA Bull/Bear, SWOT, PESTLE, matrice de sensibilité et verdict d'investissement.
Voir l'analyse complète →